Clinical trial
Myocardial Characterization of Arrhythmogenic Mitral Valve Prolapse
NCT02879825 is registered in ClinicalTrials.gov with Central Hospital, Nancy, France as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Myocardial Characterization of Arrhythmogenic Mitral Valve Prolapse
- Lead sponsor
- Central Hospital, Nancy, France
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- December 20, 2016
- Completion date
- May 31, 2021
- Enrollment
- 239 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.